Changes in serum lipid profile during the menopausal transition
- 作者: Komedina V.I.1, Yureneva S.V.1, Chagovets V.V.1, Starodubtseva N.L.1
-
隶属关系:
- Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- 期: 编号 6 (2022)
- 页面: 90-97
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249551
- DOI: https://doi.org/10.18565/aig.2022.6.90-97
- ID: 249551
如何引用文章
详细
全文:
作者简介
Veronika Komedina
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: komedina.veronika@gmail.com
PhD. Student at the Department of Gynecologic Endocrinology
Svetlana Yureneva
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: syureneva@gmail.com
Dr. Med. Sci., Professor at the Department of Obstetrics and Gynecology of the Department of Vocational Education, Leading Researcher at the Department of Gynecologic Endocrinology
Vitaliy Chagovets
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: vvchagovets@gmail.com
Ph.D., Senior Researcher, Laboratory of Proteomics and Metabolomics of Human Reproduction
Natalia Starodubtseva
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: n_starodubtseva@oparina4.ru
PhD, Head of the Laboratory of Proteomics and Metabolomics of Human Reproduction
参考
- El Khoudary S.R., Aggarwal B., Beckie T.M., Hodis H.N., Johnson A.E., Langer R.D. et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: A Scientific Statement from the American Heart Association. Circulation. 2020; 142(25): 506-32. https://dx.doi.org/10.1161/CIR.0000000000000912.
- Юренева С.В., Комедина В.И., Кузнецов С.Ю. Диагностические возможности антропометрических показателей для оценки ожирения у женщин в период менопаузального перехода. Акушерство и гинекология. 2022; 2: 72-9. [Yureneva S.V., Komedina V.I., Kuznetsov S.Yu. Diagnostic accuracy of anthropometric measures for assessing obesity in women during the menopausal transition. Akusherstvo i Ginekologiia/Obstetrics and Gynecology. 2022; 2: 72-9. (in Russian)]. https://dx.doi.org/10.18565/aig.2022.2.72-79.
- Thurston R.C., Karvonen-Gutierrez C.A., Derby C.A., El Khoudary S.R., Kravitz H.M., Manson J.E. Menopause versus chronologic aging: their roles in women’s health. Menopause. 2018; 25(8): 849-54. https://doi.org/10.1097/GME.0000000000001143.
- Юренева С.В., Комедина В.И., Чаговец В.В., Стародубцева Н.Л. Роль липидов, определяемых методом масс-спектрометрии, в развитии кардиометаболических заболеваний у женщин в период менопаузы. Акушерство и гинекология. 2020; 12: 76-80. https://dx.doi.org/10.18565/aig.2020.12.76-80.
- Neeland I.J., Singh S., McGuire D.K., Vega G.L., Roddy T., Reilly D.F. et al. Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study. Diabetologia. 2018; 61(12): 2570-9. https://dx.doi.org/10.1007/s00125-018-4720-1.
- Gui Y.-K., Li Q., Liu L., Zeng P., Ren R.F., Guo Z.F. et al. Plasma levels of ceramides relate to ischemic stroke risk and clinical severity. Brain Res. Bull. 2020; 158: 122-7. https://dx.doi.org/10.1016/J.BRAINRESBULL.2020.03.009.
- Van der Veen J.N., Kennelly J.P., Wan S., Vance J.E., Vance D.E., Jacobs R.L. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim. Biophys. Acta Biomembr. 2017; 1859 (9, Pt B): 1558-72. https://dx.doi.org/10.1016/j.bbamem.2017.04.006.
- Messina C., Albano D., Gitto S., Tofanelli L., Bazzocchi A., Ulivieri F.M. et al. Body composition with dual energy X-ray absorptiometry: From basics to new tools. Quant. Imaging Med. Surg. 2020; 10(8): 1687-98. https://dx.doi.org/10.21037/QIMS.2020.03.02.
- Tang Q., Li X., Song P., Xu L. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: developments in research and prospects for the future. Drug Discov. Ther. 2015; 9(6): 380-5. https://dx.doi.org/10.5582/ddt.2015.01207.
- Bovolini A., Garcia J., Andrade M.A., Duarte J.A. Metabolic syndrome pathophysiology and redisposing factors. Int. J. Sports Med. 2021; 42(3): 199-214. https://dx.doi.org/10.1055/a-1263-0898.
- Choi R.H., Tatum S.M., Symons J.D., Summers S.A., Holland W.L. Ceramides and other sphingolipids as drivers of cardiovascular disease. Nature reviews. Cardiology. 2021;18(10): 701-11. https://dx.doi.org/10.1038/s41569-021-00536-1.
- Mantovani A., Bonapace S., Lunardi G., Canali G., Dugo C., Vinco G. et al. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography. Diabet. Metab. 2020; 46(2): 150-7. https://dx.doi.org/10.1016/j.diabet.2019.07.006.
- Fretts A.M., Jensen P.N., Hoofnagle A., McKnight B., Howard B.V., Umans J. et al. Plasma ceramide species are associated with diabetes risk in participants of the Strong Heart Study. J. Nutr. 2020; 150(5): 1214-22. https://dx.doi.org/10.1093/jn/nxz259.
- Wigger L., Cruciani-Guglielmacci C., Nicolas A., Denom J., Fernandez N., Fumeron F. et al. Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans. Cell Rep. 2017; 18(9): 2269-79. https://dx.doi.org/10.1016/j.celrep.2017.02.019.
- Im S.-S., Park H.Y., Shon J.C., Chung I.-S., Cho H.C., Liu K.-H. et al. Plasma sphingomyelins increase in pre-diabetic Korean men with abdominal obesity. PLoS ONE. 2019; 14: e0213285. https://dx.doi.org/10.1371/journal.pone.0213285.
- Kikas P., Chalikias G. Cardiovascular implications of sphingomyelin presence in biological membranes. Eur. Cardiol. Rev. 2018; 13: 42. https://dx.doi.org/10.15420/ecr.2017:20:3.
- Bochkov V., Gesslbauer B., Mauerhofer C., Philippova M., Erne P., Oskolkova O.V. Pleiotropic effects of oxidized phospholipids. Free Rad. Biol. Med. 2017; 111: 6-24. https://dx.doi.org/10.1016/j.freeradbiomed.2016.12.034.
- Lopez-Lopez A., Godzien J., Soldevilla B., Gradillas A., LopezGonzdlvez A., Lens-Pardo A. et al. Oxidized lipids in the metabolic profiling of neuroendocrine tumors - Analytical challenges and biological implications. J. Chromatogr. A. 2020; 1625: 461233. https://dx.doi.org/10.1016/j.chroma.2020.461233.
- Nie J., Yang J., Wei Y., Wei X. The role of oxidized phospholipids in the development of disease. Mol. Aspects Med. 2020; 76: 100909. https://dx.doi.org/10.1016/J.MAM.2020.100909.
- Furse S., de Kroon A.I.P.M. Phosphatidylcholine’s functions beyond that of a membrane brick. Mol. Membr. Biol. 2015; 32(4): 117-9. https://dx.doi.org/10.3109/09687688.2015.1066894.
- Calzada E., Onguka O., Claypool S.M. Phosphatidylethanolamine metabolism in health and disease. Int. Rev. Cell Mol. Biol. 2016; 321: 29-88. https://dx.doi.org/10.1016/bs.ircmb.2015.10.001.
- Llano D.A., Devanarayan V. Serum phosphatidylethanolamine and lysophosphatidylethanolamine levels differentiate Alzheimer’s disease from controls and predict progression from mild cognitive impairment. J. Alzheimers Dis. 2021; 80(1): 311-9. https://dx.doi.org/10.3233/JAD-201420.